FDA
label_change
· 2016-02-11
FDA Approved: CLINDESSE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
Summary
FDA approved a supplemental application for CLINDESSE (clindamycin phosphate) from Padagis Israel Pharmaceuticals Ltd, updating the product labeling.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CLINDESSE (CLINDAMYCIN PHOSPHATE)